Variant report
Variant | nsv556195 |
---|---|
Chromosome Location | chr11:104267449-104272940 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:104266914..104269126-chr11:104273371..104275072,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4755029 | chr11:104267449-104267450 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs531934931 | chr11:104267455-104267456 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11425883 | chr11:104267470-104267471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs397973576 | chr11:104267472-104267473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373812309 | chr11:104267560-104267561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547499416 | chr11:104267598-104267599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138089419 | chr11:104267600-104267601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562153130 | chr11:104267617-104267618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527929128 | chr11:104267645-104267646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567234125 | chr11:104267747-104267748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs368323719 | chr11:104267752-104267753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs372328045 | chr11:104267753-104267754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374672389 | chr11:104267754-104267755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113070442 | chr11:104267930-104267931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533330084 | chr11:104267942-104267943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs116476898 | chr11:104267944-104267945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200203704 | chr11:104267960-104267961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375001388 | chr11:104267961-104267962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs386374744 | chr11:104267963-104267964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10635150 | chr11:104267964-104267965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188142443 | chr11:104268024-104268025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373834828 | chr11:104268026-104268027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs192887455 | chr11:104268028-104268029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375694813 | chr11:104268036-104268037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549296813 | chr11:104268076-104268077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71464733 | chr11:104268095-104268096 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs182695531 | chr11:104268111-104268112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186567506 | chr11:104268128-104268129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs367869542 | chr11:104268136-104268137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370578771 | chr11:104268177-104268178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs527644099 | chr11:104268218-104268219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565557037 | chr11:104268222-104268223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs527631933 | chr11:104268223-104268224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75422382 | chr11:104268259-104268260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373697430 | chr11:104268263-104268264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11602131 | chr11:104268265-104268266 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs368494056 | chr11:104268295-104268296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114591178 | chr11:104268324-104268325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192573541 | chr11:104268396-104268397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375567447 | chr11:104268531-104268532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542149554 | chr11:104268562-104268563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7933741 | chr11:104268565-104268566 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs142567257 | chr11:104268683-104268684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114411791 | chr11:104268717-104268718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145991809 | chr11:104268718-104268719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs533269610 | chr11:104268723-104268724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558417414 | chr11:104268748-104268749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550107119 | chr11:104268799-104268800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12417906 | chr11:104268822-104268823 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs529332990 | chr11:104268913-104268914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:104265200-104267800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr11:104266400-104267800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr11:104266600-104267800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr11:104266800-104267800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr11:104267000-104267600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr11:104267000-104267600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr11:104267400-104271600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr11:104267600-104273200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr11:104267600-104273400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
10 | chr11:104267800-104273200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr11:104267800-104273200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr11:104267800-104273200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr11:104271600-104272000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr11:104272000-104273400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr11:104272200-104273600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |